Literature DB >> 11850731

Prevalence of erectile dysfunction: need for treatment?

E J H Meuleman1.   

Abstract

Research examining the occurrence of sexual problems in nonclinical populations tends to be restricted to highly select populations. Recently, several population-based surveys surfaced in the international literature, triggered by the advent of effective pharmacological treatment for erectile dysfunction (ED). ED is a common disorder, especially among elderly men. The annual incidence in men 40-69 y of age is 26 per 1000 men. Although most of the difficulties are mild and do not totally prevent intercourse, about 26% of men experience moderate to complete ED. The impact of this category of ED on sexual activity among men is marked. The incidence of ED increases with age and the presence of concomitant conditions, such as diabetes mellitus, heart disease, hypertension, depression, pelvic surgery, negative mood, lack of self-esteem, problems with relationships, or just inadequate sexual experience. Vascular disease is thought to be the most common cause of organic ED, and it may be an early symptom of cardiac morbidity and mortality. Although one may expect that any man with ED who is motivated to continue sexual activity may seek current highly effective symptomatic medical treatment, only a few men are actually seeking help, and not every man seeking help appears to be a candidate for (symptomatic) medical treatment. The frequent association of sexual and medical problems, especially in the aged, and the high dropout rates for symptomatic ED treatment make counseling, adjustment of lifestyle, and modification of risk factors, such as medication, overweight, smoking, alcohol consumption, and lack of exercise, the primary steps in a holistic approach toward the treatment of ED. It is especially important to educate these men to remain physically and sexually as active as possible for as long as possible. The phrase 'use it or lose it' is particularly appropriate for the genitalia.

Entities:  

Mesh:

Year:  2002        PMID: 11850731     DOI: 10.1038/sj.ijir.3900793

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  11 in total

1.  Erectile function in two-kidney, one-clip hypertensive rats is maintained by a potential increase in nitric oxide production.

Authors:  A Elizabeth Linder; Anne M Dorrance; Thomas M Mills; R Clinton Webb; Romulo Leite
Journal:  J Sex Med       Date:  2009-03       Impact factor: 3.802

2.  Erectile Dysfunction and Other Sexual Activity Dysfunctions among Saudi Type 2 Diabetic Patients.

Authors:  Turki Abdullah AlMogbel
Journal:  Int J Health Sci (Qassim)       Date:  2014-10

3.  Sexual Problems Predict PTSD and Depression Symptom Change Among Male OEF/OIF Veterans Completing Exposure Therapy.

Authors:  Christal L Badour; Daniel F Gros; Derek D Szafranski; Ron Acierno
Journal:  Psychiatry       Date:  2016       Impact factor: 2.458

4.  Correlation between penile cavernosal artery blood flow and retinal vascular findings in arteriogenic erectile dysfunction.

Authors:  Ahmed M Emarah; Shawky M El-Haggar; Ihab A Osman; Abdel Wahab S Khafagy
Journal:  Clin Ophthalmol       Date:  2010-09-20

5.  Murine and rat cavernosal responses to endothelin-1 and urotensin-II Vasoactive Peptide Symposium.

Authors:  Fernando S Carneiro; Zidonia N Carneiro; Fernanda R C Giachini; Victor V Lima; Edson Nogueira; William E Rainey; Rita C Tostes; R Clinton Webb
Journal:  J Am Soc Hypertens       Date:  2008-11

Review 6.  Treatment of benign prostatic hyperplasia in hypertensive men.

Authors:  William B White; Timothy Moon
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-04       Impact factor: 3.738

7.  Sildenafil and suicide in Sweden.

Authors:  Ralph Catalano; Sidra Goldman-Mellor; Tim A Bruckner; Terry Hartig
Journal:  Eur J Epidemiol       Date:  2021-04-01       Impact factor: 8.082

Review 8.  Tadalafil in the treatment of erectile dysfunction; an overview of the clinical evidence.

Authors:  Giovanni Vanni Frajese; Flavio Pozzi; Gaetano Frajese
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

9.  Testosterone deficiency with erectile dysfunction in mongolian men.

Authors:  Nansalmaa Naidan; Oyun-Erdene Rivaad; Namsrai Muukhai; Munkhtsetseg Janlav
Journal:  World J Mens Health       Date:  2013-08-31       Impact factor: 5.400

10.  Prevalence of erectile dysfunction and associated factors among diabetic men attending diabetic clinic at Muhimbili National Hospital in Dar-es-Salaam, Tanzania.

Authors:  Reuben Kato Mutagaywa; Janeth Lutale; Muhsin Aboud; Benjamin Anathory Kamala
Journal:  Pan Afr Med J       Date:  2014-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.